Cerebellar Ataxia Clinical Trials 2022
Browse 24 Cerebellar Ataxia Medical Studies Across 33 Cities
6 Phase 3 Trial · 110 Cerebellar Ataxia Clinics
Reviewed by Michael Gill, B. Sc.
24 Cerebellar Ataxia Clinical Trials Near Me
Top Hospitals for Cerebellar Ataxia Clinical Trials
University of South Florida
Tampa
7Active Trials
18All Time Trials for Cerebellar Ataxia
2009First Cerebellar Ataxia Trial
UCLA
Los Angeles
5Active Trials
6All Time Trials for Cerebellar Ataxia
2015First Cerebellar Ataxia Trial
University of Florida
Gainesville
3Active Trials
11All Time Trials for Cerebellar Ataxia
2009First Cerebellar Ataxia Trial
University of Iowa
Iowa City
3Active Trials
3All Time Trials for Cerebellar Ataxia
2020First Cerebellar Ataxia Trial
Top Cities for Cerebellar Ataxia Clinical Trials
Cerebellar Ataxia Clinical Trials by Phase of Trial
Phase 1 Cerebellar Ataxia Clinical Trials
6Active Cerebellar Ataxia Clinical Trials
6Number of Unique Treatments
26Number of Active Locations
Cerebellar Ataxia Clinical Trials by Age Group
Most Recent Cerebellar Ataxia Clinical Trials
Top Treatments for Cerebellar Ataxia Clinical TrialsClinical Trial
Began Recruiting Date
Phase
Treatment Name
Active Cerebellar Ataxia Clinical Trials
All Time Trials for Cerebellar Ataxia
First Recorded Cerebellar Ataxia Trial
Vatiquinone
3
3
2020
Sham tPCS
1
1
2023
CTI-160l
1
1
2022
Multiple Dose: DT-216
1
1
2022
SLS-005
1
1
2022
About The Author
Michael Gill - B. Sc.
First Published: October 13th, 2021
Last Reviewed: November 22nd, 2022
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Relevant Clinical Trials
Top Oncology Trials
Popular Clinical Trials
References1 Rossi S, Hallett M, Rossini PM, Pascual-Leone A; Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009 Dec;120(12):2008-2039. doi: 10.1016/j.clinph.2009.08.016. Epub 2009 Oct 14. Review. https://pubmed.ncbi.nlm.nih.gov/198335522 Huang YZ, Edwards MJ, Rounis E, Bhatia KP, Rothwell JC. Theta burst stimulation of the human motor cortex. Neuron. 2005 Jan 20;45(2):201-6. https://pubmed.ncbi.nlm.nih.gov/156641723 Huang YZ, Edwards MJ, Rounis E, Bhatia KP, Rothwell JC. Theta burst stimulation of the human motor cortex. Neuron. 2005 Jan 20;45(2):201-6. doi: 10.1016/j.neuron.2004.12.033. https://pubmed.ncbi.nlm.nih.gov/156641724 Antal A, Alekseichuk I, Bikson M, Brockmöller J, Brunoni AR, Chen R, Cohen LG, Dowthwaite G, Ellrich J, Flöel A, Fregni F, George MS, Hamilton R, Haueisen J, Herrmann CS, Hummel FC, Lefaucheur JP, Liebetanz D, Loo CK, McCaig CD, Miniussi C, Miranda PC, Moliadze V, Nitsche MA, Nowak R, Padberg F, Pascual-Leone A, Poppendieck W, Priori A, Rossi S, Rossini PM, Rothwell J, Rueger MA, Ruffini G, Schellhorn K, Siebner HR, Ugawa Y, Wexler A, Ziemann U, Hallett M, Paulus W. Low intensity transcranial electric stimulation: Safety, ethical, legal regulatory and application guidelines. Clin Neurophysiol. 2017 Sep;128(9):1774-1809. doi: 10.1016/j.clinph.2017.06.001. Epub 2017 Jun 19. Review. https://pubmed.ncbi.nlm.nih.gov/287098805 Oberman L, Edwards D, Eldaief M, Pascual-Leone A. Safety of theta burst transcranial magnetic stimulation: a systematic review of the literature. J Clin Neurophysiol. 2011 Feb;28(1):67-74. doi: 10.1097/WNP.0b013e318205135f. Review. https://pubmed.ncbi.nlm.nih.gov/212210116 Oberman L, Edwards D, Eldaief M, Pascual-Leone A. Safety of theta burst transcranial magnetic stimulation: a systematic review of the literature. J Clin Neurophysiol. 2011 Feb;28(1):67-74. doi: 10.1097/WNP.0b013e318205135f. https://pubmed.ncbi.nlm.nih.gov/212210117 Antal A, Alekseichuk I, Bikson M, Brockmoller J, Brunoni AR, Chen R, Cohen LG, Dowthwaite G, Ellrich J, Floel A, Fregni F, George MS, Hamilton R, Haueisen J, Herrmann CS, Hummel FC, Lefaucheur JP, Liebetanz D, Loo CK, McCaig CD, Miniussi C, Miranda PC, Moliadze V, Nitsche MA, Nowak R, Padberg F, Pascual-Leone A, Poppendieck W, Priori A, Rossi S, Rossini PM, Rothwell J, Rueger MA, Ruffini G, Schellhorn K, Siebner HR, Ugawa Y, Wexler A, Ziemann U, Hallett M, Paulus W. Low intensity transcranial electric stimulation: Safety, ethical, legal regulatory and application guidelines. Clin Neurophysiol. 2017 Sep;128(9):1774-1809. doi: 10.1016/j.clinph.2017.06.001. Epub 2017 Jun 19. https://pubmed.ncbi.nlm.nih.gov/287098808 Goodkin DE, Hertsgaard D, Seminary J. Upper extremity function in multiple sclerosis: improving assessment sensitivity with box-and-block and nine-hole peg tests. Arch Phys Med Rehabil. 1988 Oct;69(10):850-4. https://pubmed.ncbi.nlm.nih.gov/31784539 Rudick R, Antel J, Confavreux C, Cutter G, Ellison G, Fischer J, Lublin F, Miller A, Petkau J, Rao S, Reingold S, Syndulko K, Thompson A, Wallenberg J, Weinshenker B, Willoughby E. Clinical outcomes assessment in multiple sclerosis. Ann Neurol. 1996 Sep;40(3):469-79. Review. https://pubmed.ncbi.nlm.nih.gov/879754110 Koeppen AH. Friedreich's ataxia: pathology, pathogenesis, and molecular genetics. J Neurol Sci. 2011 Apr 15;303(1-2):1-12. doi: 10.1016/j.jns.2011.01.010. Review. https://pubmed.ncbi.nlm.nih.gov/21315377
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments